• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝癌中围绕肿瘤的 CCL1 和 CCL22 表达细胞塑造了肿瘤免疫浸润。

Peritumoural CCL1 and CCL22 expressing cells in hepatocellular carcinomas shape the tumour immune infiltrate.

机构信息

Center of Integrated Protein Science Munich (CIPS-M), Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany; Department of Medicine II, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

Center of Integrated Protein Science Munich (CIPS-M), Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.

出版信息

Pathology. 2019 Oct;51(6):586-592. doi: 10.1016/j.pathol.2019.06.001. Epub 2019 Aug 21.

DOI:10.1016/j.pathol.2019.06.001
PMID:31445808
Abstract

Development, course of disease and prognosis of hepatocellular carcinomas (HCC) are strongly influenced by the immune system. Immunosuppressive regulatory T cells (Treg) have been shown to negatively impact disease progression and survival. To further understand the mechanisms of Treg attraction to HCC lesions, this study provides an analysis of Treg attracting chemokines in human HCC tissues. We analysed the expression of the Treg attracting chemokines CCL1 and CCL22 as well as the infiltration of FoxP3+ Treg and CD8+ T cells in paraffin-embedded tissue sections of 62 HCC patients. Expression of both chemokines was detected in 47 of 62 tissue slides. Chemokine expression was generally higher in tumour stroma and peritumoural liver tissue than in the tumour tissue itself. CD8+ T cells and FoxP3+ Treg were found at high levels in many tumour tissues. Intratumoural infiltration of Treg positively correlated with CCL22 levels in peritumoural liver tissue. In contrast, no correlation of Treg numbers and expression of CCL1 was detected. In summary, we describe here that the chemokines CCL1 and CCL22 are expressed in HCC tissues and, to a higher extent, in the stroma and peritumoural liver tissue. CCL22 may contribute to Treg recruitment and immunosuppression, whereas the role of CCL1 remains to be defined. It will be interesting to investigate the potential of these chemokines as drug targets for cancer therapy.

摘要

肝癌(HCC)的发展、病程和预后受免疫系统的强烈影响。已证实免疫抑制性调节性 T 细胞(Treg)会对疾病进展和生存产生负面影响。为了进一步了解 Treg 向 HCC 病变趋化的机制,本研究分析了人 HCC 组织中 Treg 趋化因子的表达。我们分析了 Treg 趋化因子 CCL1 和 CCL22 的表达以及 FoxP3+Treg 和 CD8+T 细胞在 62 例 HCC 患者石蜡包埋组织切片中的浸润情况。在 62 个组织切片中有 47 个检测到两种趋化因子的表达。趋化因子的表达在肿瘤基质和肿瘤周围肝组织中通常高于肿瘤组织本身。在许多肿瘤组织中,CD8+T 细胞和 FoxP3+Treg 表达水平较高。肿瘤内 Treg 的浸润与肿瘤周围肝组织中 CCL22 水平呈正相关。相比之下,未检测到 Treg 数量与 CCL1 表达之间的相关性。总之,我们在此描述了趋化因子 CCL1 和 CCL22 在 HCC 组织中表达,并且在基质和肿瘤周围肝组织中表达程度更高。CCL22 可能有助于 Treg 的募集和免疫抑制,而 CCL1 的作用仍有待确定。研究这些趋化因子作为癌症治疗药物靶点的潜力将是有趣的。

相似文献

1
Peritumoural CCL1 and CCL22 expressing cells in hepatocellular carcinomas shape the tumour immune infiltrate.肝癌中围绕肿瘤的 CCL1 和 CCL22 表达细胞塑造了肿瘤免疫浸润。
Pathology. 2019 Oct;51(6):586-592. doi: 10.1016/j.pathol.2019.06.001. Epub 2019 Aug 21.
2
CCL1 is a major regulatory T cell attracting factor in human breast cancer.CCL1 是人类乳腺癌中调节性 T 细胞的主要吸引因子。
BMC Cancer. 2018 Dec 20;18(1):1278. doi: 10.1186/s12885-018-5117-8.
3
Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.调节性T细胞增多与肝细胞癌患者的CD8 T细胞损伤及生存率低相关。
Gastroenterology. 2007 Jun;132(7):2328-39. doi: 10.1053/j.gastro.2007.03.102. Epub 2007 Apr 14.
4
Regulatory T cells, especially ICOS FOXP3 regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival.调节性T细胞,尤其是诱导共刺激分子(ICOS)FOXP3调节性T细胞,在肝细胞癌微环境中增多,并预示着生存期缩短。
Sci Rep. 2016 Oct 11;6:35056. doi: 10.1038/srep35056.
5
Possible involvement of CCL1-CCR8 interaction in lymphocytic recruitment in IgG4-related sclerosing cholangitis.CCL1-CCR8 相互作用可能参与 IgG4 相关硬化性胆管炎中的淋巴细胞募集。
J Hepatol. 2013 Nov;59(5):1059-64. doi: 10.1016/j.jhep.2013.06.016. Epub 2013 Jun 25.
6
Increased frequency of Foxp3+ regulatory T cells in mice with hepatocellular carcinoma.肝细胞癌小鼠中Foxp3 + 调节性T细胞频率增加。
Asian Pac J Cancer Prev. 2012;13(8):3815-9. doi: 10.7314/apjcp.2012.13.8.3815.
7
p65/miR-23a/CCL22 axis regulated regulatory T cells recruitment in hepatitis B virus positive hepatocellular carcinoma.p65/miR-23a/CCL22 轴调控乙型肝炎病毒阳性肝细胞癌中调节性 T 细胞的募集。
Cancer Med. 2020 Jan;9(2):711-723. doi: 10.1002/cam4.2611. Epub 2019 Nov 25.
8
Relationship and clinical significance of TGF-beta1 expression with Treg cell infiltration in hepatocellular carcinoma.转化生长因子-β1表达与调节性T细胞浸润在肝细胞癌中的关系及临床意义
Chin J Cancer. 2010 Apr;29(4):403-7. doi: 10.5732/cjc.009.10628.
9
FOXP3+ Cells Recruited by CCL22 into Breast Cancer Correlates with Less Tumor Nodal Infiltration.CCL22招募至乳腺癌中的FOXP3+细胞与较少的肿瘤淋巴结浸润相关。
Anticancer Res. 2016 Jun;36(6):3139-45.
10
Hepatocellular carcinoma and macrophage interaction induced tumor immunosuppression via Treg requires TLR4 signaling.肝细胞癌与巨噬细胞相互作用通过 Treg 诱导肿瘤免疫抑制需要 TLR4 信号。
World J Gastroenterol. 2012 Jun 21;18(23):2938-47. doi: 10.3748/wjg.v18.i23.2938.

引用本文的文献

1
Targeting tumor-associated macrophages to overcome immune checkpoint inhibitor resistance in hepatocellular carcinoma.靶向肿瘤相关巨噬细胞以克服肝细胞癌中免疫检查点抑制剂耐药性
J Exp Clin Cancer Res. 2025 Aug 5;44(1):227. doi: 10.1186/s13046-025-03490-9.
2
Macrophage fatty acid metabolism under chronic hypoxia shapes γδ T cell recruitment via CCL22.慢性缺氧条件下巨噬细胞的脂肪酸代谢通过CCL22影响γδ T细胞募集。
iScience. 2025 Jun 27;28(8):113025. doi: 10.1016/j.isci.2025.113025. eCollection 2025 Aug 15.
3
Sensing antibody functions with a novel CCR8-responsive engineered cell.
利用新型 CCR8 响应型工程细胞感知抗体功能。
Acta Biochim Pol. 2024 Apr 29;71:12185. doi: 10.3389/abp.2024.12185. eCollection 2024.
4
Identification of key immune cells infiltrated in lung adenocarcinoma microenvironment and their related long noncoding RNA.肺腺癌微环境中浸润的关键免疫细胞及其相关长链非编码RNA的鉴定
iScience. 2024 Feb 15;27(3):109220. doi: 10.1016/j.isci.2024.109220. eCollection 2024 Mar 15.
5
Downstream STING pathways IRF3 and NF-κB differentially regulate CCL22 in response to cytosolic dsDNA.下游的 STING 通路 IRF3 和 NF-κB 对细胞质 dsDNA 作出反应时,以不同的方式调节 CCL22。
Cancer Gene Ther. 2024 Jan;31(1):28-42. doi: 10.1038/s41417-023-00678-z. Epub 2023 Nov 21.
6
Liver Cell Type-Specific Targeting by Nanoformulations for Therapeutic Applications.纳米制剂在治疗应用中的肝实质细胞类型特异性靶向
Int J Mol Sci. 2023 Jul 24;24(14):11869. doi: 10.3390/ijms241411869.
7
Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells.子宫内膜癌中调节性 T 细胞的存在预示着总体生存率较差,并促进肿瘤细胞的进展。
Cell Oncol (Dordr). 2022 Dec;45(6):1171-1185. doi: 10.1007/s13402-022-00708-2. Epub 2022 Sep 13.
8
MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells.微小RNA作为胃癌细胞中顺铂耐药性的关键调节因子。
Genes Environ. 2021 Jun 7;43(1):21. doi: 10.1186/s41021-021-00192-4.
9
Regulation and functional roles of chemokines in liver diseases.趋化因子在肝脏疾病中的调控作用和功能。
Nat Rev Gastroenterol Hepatol. 2021 Sep;18(9):630-647. doi: 10.1038/s41575-021-00444-2. Epub 2021 May 11.
10
Analysis and Validation of Human Targets and Treatments Using a Hepatocellular Carcinoma-Immune Humanized Mouse Model.利用肝癌免疫人源化小鼠模型分析和验证人类靶点和治疗方法。
Hepatology. 2021 Sep;74(3):1395-1410. doi: 10.1002/hep.31812.